What is the use of deferoxamine injection?
Deferoxamine injection is used to remove excess iron from the body in anemia or thalassemia patients who have many blood transfusions. It is also used with other medicines to treat acute iron poisoning, especially in small children.
Which would be the most likely toxin treated with deferoxamine?
Currently, deferoxamine is used for the treatment of acute iron poisoning and iron-overload anaemias, such as thalassaemia major, as well as aluminium poisoning associated with chronic renal dialysis (Banner and Tong, 1986; Day & Ackrill, 1993).
Why deferoxamine is used in thalassemia?
Conclusions: The early use of deferoxamine in an amount proportional to the transfusional iron load reduces the body iron burden and helps protect against diabetes mellitus, cardiac disease, and early death in patients with thalassemia major.
What type of antagonist is deferoxamine?
Deferoxamine is an iron-binding agent that belongs to a class of drugs known as heavy metal antagonists.
Is deferoxamine an antidote?
Deferoxamine is used as an antidote for acute iron toxicity. Deferoxamine is used to treat individuals on dialysis with aluminum toxicity.
What type of drug is deferoxamine?
Deferoxamine is an iron-binding agent that belongs to a class of drugs known as heavy metal antagonists. It works by helping the kidneys and gallbladder get rid of the extra iron.
Why do we employ chelation therapy for thalassemia?
The objective of iron chelation is to avoid the complications of iron overload such as cardiac and hepatic dysfunction. Chelation therapy significantly improves myocardial T2* (a magnetic resonance technique for assessing tissue iron concentration) and left ventricular function.
Why desferrioxamine is used in thalassemia?
Desferrioxamine mesylate (desferrioxamine) for managing excess iron levels in the blood of people with thalassaemia who depend on blood transfusions. Haemoglobin carries oxygen in the blood. In thalassaemia, a genetic disease, sometimes the body cannot produce enough haemoglobin.
What is the mechanism of action of deferoxamine?
Deferoxamine is an Iron Chelator. The mechanism of action of deferoxamine is as an Iron Chelating Activity. Deferoxamine is an iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions.
Does deferoxamine cause liver damage?
Deferoxamine rarely causes serum aminotransferase elevations during therapy and has not been convincingly linked to instances of clinically apparent liver injury. Deferoxamine is an Iron Chelator. The mechanism of action of deferoxamine is as an Iron Chelating Activity.
How does deferoxamine work in treating iron toxicity?
Deferoxamine works in treating iron toxicity by binding trivalent (ferric) iron (for which it has a strong affinity), forming ferrioxamine, a stable complex which is eliminated via the kidneys.
What is ferrofuroxamine used to treat?
/DEFEROXAMINE IS/ A CHELATING AGENT THAT IS SPECIFIC FOR IRON. IT IS USED FOR THE TREATMENT OF SEVERE IRON INTOXICATION, IRON OVERLOAD RESULTING FROM HEMOLYSIS (FROM DRUGS, THALASSEMIA, SICKLE-CELL ANEMIA, FREQUENT BLOOD TRANSFUSIONS, ETC) OR IRON STORAGE DISEASE.